- Home
- GRNT vs PSNL Comparison
GRNT vs PSNL Comparison
Compare GRNT & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRNT | PSNL |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 662.8M | 729.1M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GRNT | PSNL |
|---|---|---|
| Price | $5.97 | $6.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $6.00 | ★ $12.20 |
| AVG Volume (30 Days) | 996.8K | ★ 1.5M |
| Earning Date | 03-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 7.53% | N/A |
| EPS Growth | 28.57 | ★ 33.58 |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $450,306,000.00 | $69,648,000.00 |
| Revenue This Year | $18.12 | $15.47 |
| Revenue Next Year | $7.47 | $39.24 |
| P/E Ratio | $32.44 | ★ N/A |
| Revenue Growth | ★ 18.49 | N/A |
| 52 Week Low | $4.18 | $2.83 |
| 52 Week High | $6.59 | $11.50 |
Technical Indicators
Market Signals| Indicator | GRNT | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 70.58 | 33.26 |
| Support Level | $5.21 | $4.65 |
| Resistance Level | $6.59 | $9.64 |
| Average True Range (ATR) | 0.18 | 0.54 |
| MACD | 0.06 | -0.07 |
| Stochastic Oscillator | 91.98 | 3.15 |
Price Performance
Historical ComparisonAbout GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.